NASDAQ-GS · traded in Congress
ImmunityBio, IBRX
$9.181 +0.001 (+0.01%) Oct 19, 2026 4:26 AM ET
Market value$9.7B
P/E ratio-
Analyst target$14.00
52-week range-
Avg volume11,184,649
Dividend yieldN/A
Chart
Congress trades in IBRX
Members of Congress disclosed 2 transactions in IBRX in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/30/2026 | Lisa McClain MI09 | Purchase | $1,001 - $15,000 | 10/12/2026 filing |
| 09/28/2026 | Lisa McClain MI09 | Purchase | $1,001 - $15,000 | 10/12/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.